Home » Topics » BioWorld Science

BioWorld Science
RSS

SRSF1 is a therapeutic target for the treatment of breast cancer

Dec. 20, 2021

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

Dec. 20, 2021

PFKFB3 targeting shows promise for treating breast cancer

Dec. 20, 2021

Researchers discover more than 1,300 genes linked to congenital heart disease

Dec. 20, 2021

Novel CD70-directed CAR-NK cells for the treatment of CD70-positive malignancies

Dec. 20, 2021

AcuraStem presents preclinical data for AS-202 in ALS

Dec. 20, 2021

REST loss promotes breast cancer tumor progression

Dec. 20, 2021

Axial Therapeutics discovers Toll-like receptor 2 agonists

Dec. 20, 2021

New three-prime repair exonuclease 1 inhibitors synthesized at Constellation Pharmaceuticals

Dec. 20, 2021

Senda Biosciences identifies aryl hydrocarbon receptor antagonists

Dec. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...